Alimera Financial Statements From 2010 to 2020

<div class='circular--portrait' style='background:#FF0F00;color: #FFFFF0;font-size:4em;padding-top: 25px;;'>AS</div>
ALIM -- USA Stock  

Fiscal Quarter End: 30th of June 2020  

Alimera Sciences financial statements provide useful quartarly and yearly information to potential investors in Alimera Sciences about the current and past financial position of the company, as well as its overall management performance and changes in basic fundamentals over time. There are over one hundred seven available fundamental signals for Alimera Sciences which can be analyzed over time and compared to other ratios. Please make sure you validate all of Alimera Sciences prevailing fundamentals over time between 2010 and 2020 to make sure the company is sustainable down the road. Alimera Sciences Tangible Asset Value is considerably stable at the moment as compared to the last year. The company current Tangible Asset Value is estimated at about 43.21 Million. Working Capital is projected to rize to about 43.8 M this year, although the value of Earnings Before Interest Taxes and Depreciation Amortization EBITDA will most likely fall to (3.4 M).

Search Fundamental Trends

 
Refresh
Check Alimera Sciences financial statements over time to gain insight into the future company performance. Apply historical fundamental analysis to find patterns among financial statement drivers such as Direct Expenses of 7.1 M, Cost of Revenue of 5.3 M or Gross Profit of 42.3 M, as well as many exotic indicators such as Long Term Debt to Equity of 13.62, PPandE Turnover of 50.72 or Receivables Turnover of 4.32. This can be a perfect complement to check Alimera Sciences Valuation or Volatility. It can also complement various Alimera Sciences Technical models. Please continue to the analysis of Alimera Sciences Correlation with competitors.

  Revenues

Alimera Sciences Balance Sheet

Current ValueLast YearHistorical Average 10 Year Trend
Total Assets75 M50.3 M54.7 M
Increasing
Slightly volatile
Cash and Equivalents7.9 M9.5 M26.7 M
Decreasing
Stable
Investments461.8 K450 K2.8 M
Decreasing
Slightly volatile
Investments Current461.8 K450 K2.8 M
Decreasing
Slightly volatile
Property Plant and Equipment Net1.7 MM1.3 M
Increasing
Slightly volatile
Inventory1.6 M1.4 M1.3 M
Increasing
Slightly volatile
Tax Assets745.6 K734 K451.2 K
Increasing
Slightly volatile
Trade and Non Trade Receivables16.2 M19.3 M8.2 M
Increasing
Slightly volatile
Trade and Non Trade Payables6.3 M7.1 M4.9 M
Increasing
Slightly volatile
Goodwill and Intangible Assets16 M14.8 M21.1 M
Decreasing
Slightly volatile
Total Liabilities49.1 M54.8 M51.6 M
Decreasing
Stable
Shareholders Equity(4.6 M)(4.4 M)344 K
Increasing
Stable
Accumulated Retained Earnings Deficit(418.2 M)(387.6 M)(318.9 M)
Decreasing
Slightly volatile
Accumulated Other Comprehensive Income(1.2 M)(1.1 M)(844.4 K)
Decreasing
Slightly volatile
Current Assets51.6 M32.7 M40.5 M
Increasing
Stable
Assets Non Current16.3 M17.6 M13.6 M
Increasing
Slightly volatile
Current Liabilities7.9 M12 M11.8 M
Increasing
Very volatile
Liabilities Non Current37.8 M42.7 M39.5 M
Decreasing
Stable
Total Debt40.2 M39 M25.5 M
Increasing
Slightly volatile
Debt Current261.7 K255 K4.1 M
Decreasing
Very volatile
Debt Non Current30.9 M38.8 M20.5 M
Increasing
Slightly volatile
Shareholders Equity USD(4.6 M)(4.4 M)344 K
Increasing
Stable
Cash and Equivalents USD9.7 M9.5 M26.8 M
Decreasing
Stable
Total Debt USD33.5 M39 M24.8 M
Increasing
Slightly volatile
Accounts Payable7.6 M7.1 M4.4 M
Increasing
Slightly volatile
Receivables20.9 M19.3 M8.7 M
Increasing
Slightly volatile
Inventories1.3 M1.4 M1.3 M
Increasing
Slightly volatile

Alimera Sciences Income Statement

Current ValueLast YearHistorical Average 10 Year Trend
Revenues52.1 M53.9 M23.7 M
Increasing
Slightly volatile
Cost of Revenue5.3 M6.6 MM
Increasing
Slightly volatile
Selling General and Administrative Expense36 M39 M29.2 M
Increasing
Slightly volatile
Research and Development Expense12.4 M11 M11.4 M
Increasing
Stable
Operating Expenses50.4 M52.6 M41.9 M
Increasing
Slightly volatile
Interest Expense4.3 M4.9 M3.3 M
Increasing
Slightly volatile
Income Tax Expense206.4 K216 K169.4 K
Increasing
Very volatile
Net Loss Income from Discontinued Operations(3.9 M)(3.6 M)(4 M)
Increasing
Slightly volatile
Consolidated Income(11.3 M)(10.4 M)(26.6 M)
Increasing
Slightly volatile
Net Income(12 M)(10.4 M)(26.7 M)
Increasing
Slightly volatile
Preferred Dividends Income Statement Impact(35.4 M)(34.5 M)(18.1 M)
Decreasing
Slightly volatile
Net Income Common Stock(11.3 M)(10.4 M)(24.4 M)
Increasing
Slightly volatile
Weighted Average SharesM4.8 M3.2 M
Increasing
Slightly volatile
Weighted Average Shares Diluted4.2 M4.8 M3.2 M
Increasing
Slightly volatile
Earning Before Interest and Taxes EBIT(5.8 M)(5.4 M)(23.1 M)
Increasing
Slightly volatile
Revenues USD45.2 M53.9 M23.1 M
Increasing
Slightly volatile
Net Income Common Stock USD(11.3 M)(10.4 M)(24.4 M)
Increasing
Slightly volatile
Earning Before Interest and Taxes USD(5.8 M)(5.4 M)(23.1 M)
Increasing
Slightly volatile
Gross Profit42.3 M47.3 M20.4 M
Increasing
Slightly volatile
Operating Income(5.7 M)(5.3 M)(21.3 M)
Increasing
Slightly volatile
Direct Expenses7.1 M6.6 M3.2 M
Increasing
Slightly volatile

Alimera Sciences Cash Flow Statement

Current ValueLast YearHistorical Average 10 Year Trend
Capital Expenditure(187.7 K)(174 K)(311.3 K)
Increasing
Very volatile
Net Cash Flow Investment Acquisitions and Disposals620.4 K575 K381.2 K
Increasing
Very volatile
Net Cash Flow from Financing891.9 K869 K17.5 M
Decreasing
Stable
Issuance Repayment of Debt Securities (33.9 K)(33 K)2.4 M
Decreasing
Very volatile
Issuance Purchase of Equity Shares925.7 K902 K6.9 M
Increasing
Very volatile
Net Cash Flow from Investing(187.7 K)(174 K)(190.4 K)
Decreasing
Stable
Net Cash Flow from Operations(3.9 M)(4.2 M)(20.4 M)
Increasing
Slightly volatile
Effect of Exchange Rate Changes on Cash (171.6 K)(159 K)(43.6 K)
Decreasing
Slightly volatile
Net Cash Flow or Change in Cash and Cash Equivalents(3.7 M)(3.6 M)(3.3 M)
Decreasing
Very volatile
Share Based CompensationM2.5 M3.2 M
Increasing
Slightly volatile
Depreciation Amortization and Accretion2.2 M2.6 M1.6 M
Increasing
Slightly volatile

Financial Ratios

Current ValueLast YearHistorical Average 10 Year Trend
Earnings per Basic Share(2.3629)(2.19)(54.7257)
Increasing
Slightly volatile
Earnings per Diluted Share(2.55)(2.19)(54.7455)
Increasing
Slightly volatile
Earnings per Basic Share USD(2.3629)(2.19)(54.7257)
Increasing
Slightly volatile
Return on Average Equity0.03232.9930.0026
Increasing
Stable
Return on Average Assets(0.0023)(0.209)(0.4168)
Increasing
Slightly volatile
Return on Invested Capital(0.1088)(0.106)0.8847
Decreasing
Very volatile
Gross Margin0.90620.8770.5725
Increasing
Slightly volatile
Profit Margin(0.2093)(0.194)(10.5987)
Increasing
Slightly volatile
EBITDA Margin(0.0539)(0.05)(9.4275)
Increasing
Slightly volatile
Return on Sales(0.1068)(0.099)(9.5002)
Increasing
Slightly volatile
Asset Turnover0.85551.0810.4083
Increasing
Slightly volatile
Enterprise Value over EBITDA(25.9063)(25.242)(10.0178)
Decreasing
Slightly volatile
Enterprise Value over EBIT(14.0263)(13.0)(7.6388)
Decreasing
Very volatile
Price to Earnings Ratio1.65(3.461)(3.1711)
Increasing
Slightly volatile
Sales per Share9.9811.3085.5705
Increasing
Slightly volatile
Price to Sales Ratio0.790.6732.3166
Decreasing
Slightly volatile
Price to Book Value13.16(8.465)1.9062
Increasing
Stable
Debt to Equity Ratio0.6134(12.318)0.8649
Increasing
Very volatile
Current Ratio1.982.7183.8524
Decreasing
Stable
Free Cash Flow per Share1.59(0.907)(22.612)
Increasing
Slightly volatile
Book Value per Share(1.0056)(0.932)(143)
Increasing
Slightly volatile
Tangible Assets Book Value per Share7.647.44718.9117
Decreasing
Slightly volatile
Total Assets Per Share10.410.130818.1628
Decreasing
Slightly volatile
Cash Flow Per Share(0.9021)(0.8361)(7.6948)
Increasing
Slightly volatile
Return on Investment(15.0344)(13.9343)(83.2228)
Increasing
Slightly volatile
Operating Margin(11.58)(9.777)(59.5924)
Increasing
Slightly volatile
Receivables Turnover4.322.94857.5353
Decreasing
Slightly volatile
Inventory Turnover3.773.4922.1236
Increasing
Slightly volatile
PPandE Turnover50.7247.009218.2433
Increasing
Slightly volatile
Cash and Equivalents Turnover5.184.80151.4333
Increasing
Slightly volatile
Accounts Payable Turnover6.538.0324.3588
Increasing
Slightly volatile
Accrued Expenses Turnover10.2812.90666.6872
Increasing
Slightly volatile
Long Term Debt to Equity13.6212.624.1344
Increasing
Slightly volatile
Quick Ratio1.81.75163.2081
Decreasing
Slightly volatile
Net Current Assets as percentage of Total Assets55.1641.139857.6225
Decreasing
Slightly volatile
Revenue to Assets1.161.07220.4513
Increasing
Slightly volatile

Alimera Sciences Valuation Data

Current ValueLast YearHistorical Average 10 Year Trend
Earnings per Basic Share(2.3629)(2.19)(54.7257)
Increasing
Slightly volatile
Earnings per Diluted Share(2.55)(2.19)(54.7455)
Increasing
Slightly volatile
Earnings before Tax(11 M)(10.2 M)(26.5 M)
Increasing
Slightly volatile
Earnings Before Interest Taxes and Depreciation Amortization EBITDA(3.4 M)(2.7 M)(21.5 M)
Increasing
Slightly volatile
Earnings per Basic Share USD(2.3629)(2.19)(54.7257)
Increasing
Slightly volatile
Earnings Before Interest Taxes and Depreciation Amortization USD(2.9 M)(2.7 M)(21.5 M)
Increasing
Slightly volatile
Market Capitalization40.9 M37.6 M109.6 M
Decreasing
Slightly volatile
Enterprise Value103.6 M68.6 M111.1 M
Decreasing
Stable
Invested Capital42.1 M53 M25.8 M
Increasing
Slightly volatile
Average Equity(3.6 M)(3.5 M)14 M
Decreasing
Slightly volatile
Average Assets57.9 M49.9 M54.9 M
Increasing
Slightly volatile
Invested Capital Average40.4 M50.5 M25.4 M
Increasing
Slightly volatile
Tangible Asset Value43.2 M35.5 M41.1 M
Increasing
Stable
Return on Average Equity0.03232.9930.0026
Increasing
Stable
Return on Average Assets(0.0023)(0.209)(0.4168)
Increasing
Slightly volatile
Free Cash Flow(4.7 M)(4.3 M)(20.8 M)
Increasing
Slightly volatile
Return on Invested Capital(0.1088)(0.106)0.8847
Decreasing
Very volatile
Gross Margin0.90620.8770.5725
Increasing
Slightly volatile
Profit Margin(0.2093)(0.194)(10.5987)
Increasing
Slightly volatile
EBITDA Margin(0.0539)(0.05)(9.4275)
Increasing
Slightly volatile
Return on Sales(0.1068)(0.099)(9.5002)
Increasing
Slightly volatile
Asset Turnover0.85551.0810.4083
Increasing
Slightly volatile
Enterprise Value over EBITDA(25.9063)(25.242)(10.0178)
Decreasing
Slightly volatile
Enterprise Value over EBIT(14.0263)(13.0)(7.6388)
Decreasing
Very volatile
Price to Earnings Ratio1.65(3.461)(3.1711)
Increasing
Slightly volatile
Sales per Share9.9811.3085.5705
Increasing
Slightly volatile
Price to Sales Ratio0.790.6732.3166
Decreasing
Slightly volatile
Price to Book Value13.16(8.465)1.9062
Increasing
Stable
Debt to Equity Ratio0.6134(12.318)0.8649
Increasing
Very volatile
Current Ratio1.982.7183.8524
Decreasing
Stable
Working Capital43.8 M20.7 M28.7 M
Increasing
Stable
Free Cash Flow per Share1.59(0.907)(22.612)
Increasing
Slightly volatile
Book Value per Share(1.0056)(0.932)(143)
Increasing
Slightly volatile
Tangible Assets Book Value per Share7.647.44718.9117
Decreasing
Slightly volatile
Total Assets Per Share10.410.130818.1628
Decreasing
Slightly volatile
Cash Flow Per Share(0.9021)(0.8361)(7.6948)
Increasing
Slightly volatile
Revenue Per Employee458.3 K424.7 K210.2 K
Increasing
Slightly volatile
Net Income Per Employee(88.7 K)(82.2 K)(471.2 K)
Increasing
Slightly volatile
Return on Investment(15.0344)(13.9343)(83.2228)
Increasing
Slightly volatile
Operating Margin(11.58)(9.777)(59.5924)
Increasing
Slightly volatile
Receivables Turnover4.322.94857.5353
Decreasing
Slightly volatile
Inventory Turnover3.773.4922.1236
Increasing
Slightly volatile
PPandE Turnover50.7247.009218.2433
Increasing
Slightly volatile
Cash and Equivalents Turnover5.184.80151.4333
Increasing
Slightly volatile
Accounts Payable Turnover6.538.0324.3588
Increasing
Slightly volatile
Accrued Expenses Turnover10.2812.90666.6872
Increasing
Slightly volatile
Long Term Debt to Equity13.6212.624.1344
Increasing
Slightly volatile
Quick Ratio1.81.75163.2081
Decreasing
Slightly volatile
Net Current Assets as percentage of Total Assets55.1641.139857.6225
Decreasing
Slightly volatile
Revenue to Assets1.161.07220.4513
Increasing
Slightly volatile

Alimera Fundamental Market Drivers

Forward Price Earnings-11.30
Short Percent Of Float0.06%
Average Daily Volume Last 10 Day15.53k
Shares Short Prior Month4.99k
Average Daily Volume In Three Month33.54k
Date Short Interest30th of April 2020
Fifty Day Average4.85
Two Hundred Day Average5.74

Alimera Upcoming Events

Upcoming Quarterly Report3rd of August 2020
Next Earnings Report3rd of November 2020
Next Fiscal Quarter End30th of June 2020
Next Fiscal Year End24th of February 2021
Last Quarter Report31st of March 2020
Last Earning Anouncement30th of June 2019

About Alimera Sciences Financial Statement Charts

There are typically three primary documents that fall into the category of financial statements. These documents include Alimera Sciences income statement, its balance sheet, and the statement of cash flows. Alimera Sciences investors use historical funamental indicators, such as Alimera Sciences's revenue or net income, to determine how well the company is positioned to perform in the future. Although Alimera Sciences investors may use each financial statement separately, they are all related. The changes in Alimera Sciences's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Alimera Sciences's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Alimera Sciences Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Alimera Sciences. Please read more on our technical analysis and fundamental analysis pages.

Current Sentiment - ALIM

Alimera Sciences Investor Sentiment

Most of Macroaxis users are presently bullish on Alimera Sciences. What is your sentiment towards investing in Alimera Sciences? Are you bullish or bearish?
Bullish
Bearish
98% Bullish
2% Bearish
Skip

Alimera Sciences Pair Correlation

Equities Pair Trading Analysis

Correlation analysis and pair trading evaluation for Alimera Sciences and DURECT. Pair trading can be used as a hedging technique within a particular sector or industry or even over random equities to generate better risk-adjusted return
Run Pair Correlation  
Please continue to the analysis of Alimera Sciences Correlation with competitors. Please also try Equity Analysis module to research over 250,000 global equities including funds, stocks and etfs to find investment opportunities.
Macroaxis is not a registered investment advisor or broker/dealer. All investments, including stocks, funds, ETFs, or cryptocurrencies, are speculative and involve substantial risk of loss. We encourage our investors to invest carefully. Much of our information is derived directly from data published by companies or submitted to governmental agencies which we believe are reliable, but are without our independent verification. Therefore, we cannot assure you that the information is accurate or complete. We do not in any way warrant or guarantee the success of any action you take in reliance on our statements or recommendations. Also, note that past performance is not necessarily indicative of future results. All investments carry risk, and all investment decisions of an individual remain the responsibility of that individual. There is no guarantee that systems, indicators, or signals will result in profits or that they will not result in losses. All investors are advised to fully understand all risks associated with any investing they choose to do. Hypothetical or simulated performance is not indicative of future results. We make no representations or warranties that any investor will, or is likely to, achieve profits similar to those shown because hypothetical or simulated performance is not necessarily indicative of future results. For more information please visit our terms and condition page